Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 15 The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Authors Dong M , Wen S , Zhou L Received 21 May 2022 Accepted for publication 12 August 2022 Published 22 August 2022 Volume 2022:15 Pages 25832597 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Professor Ming-Hui Zou Meiyuan Dong, 1 Song Wen, 1 Ligang Zhou 1, 2 1 Department of Endocrinology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, 201399, Peoples Republic of China
Do Not Use If Solution is Not Clear or Container is Damaged
Scroll down to know the benefits and side effects of this injection
However, each discontinuation carries the risk of weight regain, increased appetite, and potential negative metabolic shifts